Replies to post #743825 on NorthWest Biotherapeutics Inc (NWBO)

[flipper44]

Edit: Thanks Stonk, this is what I meant by MHRA National MAA review averages (NAS MAA) could/should dramatically improve because the chart is only looking at a month’s averages per chart. 🙂

🤞

(MHRA is working very steadily to completely eliminate backlog)

Also see:

flipper44
Member Level
Re: manibiotech post# 743827
Wednesday, 01/15/2025 12:13:38 PM

Actually, think about that for a minute. If we took the normal 60 days clock off to respond, we are 43 days over the average clock on review time. If we took the full 60 days additional clock off (I doubt we took this much if we took any), then that leaves 17 days* (or less) to fall within the average. Looking back at what LP said, she indicated it could be 60 days clock off or somewhere in between 60 and 120 days. A few long in tooth longs have been chanting remember this might take a little bit longer due to two indications being reviewed. I suppose that might be more likely for the clock off then the clock on.

Anyway, the argument that I think is bunk, is page length delay. Instead, 1.7 million pages is just not exceptional for MHRA reviews.

Net net, we are squarely within the likelyhood of decision window if not in the latter one-third of it. IMO.

(*Note: 17 days from today is Saturday, February 1, 2025)